Benefit of Vitamin B-12 supplementation in asymptomatic elderly: A matter of endpoints

American Journal of Clinical Nutrition

Volumn 102, Issue 3, 2015, Pages 529-530

  Kalita, Jayantee ^a   Misra, Usha Kant ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; HOMOCYSTEINE; METHIONINE; METHYLMALONIC ACID; TRANSCOBALAMIN II;

AGED; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DRUG MEGADOSE; EDITORIAL; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; GERIATRIC NUTRITION; HUMAN; MINI MENTAL STATE EXAMINATION; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NEUROLOGIC DISEASE; NONHUMAN; PERNICIOUS ANEMIA; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBACUTE COMBINED DEGENERATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; CENTRAL NERVOUS SYSTEM; COGNITION; DIET SUPPLEMENTATION; DRUG EFFECTS; FEMALE; MALE;

CENTRAL NERVOUS SYSTEM; COGNITION; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; VITAMIN B 12;

EID: 84941633097     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.118380     Document Type: Editorial

References (12)

1. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
2. Kalita J, Agarwal R, Chandra S, Misra UK. A study of neurobehavioral, clinical psychometric, and P3 changes in vitamin B12 deficiency neurological syndrome. Nutr Neurosci 2013;16:39-46.
3. Misra UK, Kalita J. Comparison of clinical and electrodiagnostic features in B12 deficiency neurological syndromes with and without antiparietal cell antibodies. Postgrad Med J 2007;83:124-7.
4. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70: 229-45.
5. Kalita J, Misra UK. Vitamin B12 deficiency neurological syndromes: correlation of clinical, MRI and cognitive evoked potential. J Neurol 2008;255:353-9.
6. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
7. Dangour AD, Allen E, Clarke R, Elbourne D, Fletcher AE, Letley L, Richards M, Whyte K, Uauy R, Mills K. Effects of Vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. Am J Clin Nutr 2015;102:639-47.
8. Kalita J, Chandra S, Bhoi SK, Agarwal R, Misra UK, Shankar SK, Mahadevan A. Clinical, nerve conduction and nerve biopsy study in vitamin B12 deficiency neurological syndrome with a short-term followup. Nutr Neurosci 2014;17:156-63.
9. Carmel R, Gott PS, Waters CH, Cairo K, Green R, Bondareff W, DeGiorgio CM, Cummings JL, Jacobsen DW, Buckwalter G, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995;54:245-53.
10. Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lücking CH. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998; 65:822-7.
11. Werder SF. Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat 2010;6:159-95.
12. Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E. Heart Outcomes Prevention Evaluation 2 Investigators. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 2009;40:1365-72.